Format

Send to

Choose Destination
Cutis. 1989 Jan;43(1):94-8.

Topical minoxidil: review of efficacy and safety.

Author information

1
Department of Dermatology, University of Minnesota, Minneapolis.

Abstract

Topical minoxidil (Rogaine) has recently been approved by the Food and Drug Administration for treatment of androgenetic alopecia. It has been approved for such use in many other countries. This paper is a review and summary of the reported efficacy and safety of topical minoxidil in the treatment of androgenetic alopecia. The results of anecdotal and controlled clinical trials are included. Realistic appraisal of the restorative and/or preventative potentials of topical minoxidil in androgenetic alopecia is needed.

PMID:
2644080
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center